Pre Transplant Dental denied as not FDA-approved for this use by Humana?
Off-label use is widespread in medicine. If the literature and a recognised specialty-society guideline support the use, plans frequently approve on appeal — especially for cancer, cardiology, and rare disease.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for pre transplant dental are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Pre Transplant Dental
## Why Humana Issues a "Not FDA-Approved" Denial for Pre-Transplant Dental
This denial category is almost certainly a classification error. Dental procedures — extractions, periodontal treatment, oral surgery — are not drugs or devices subject to FDA drug-approval pathways. A "not FDA-approved" denial applied to pre-transplant dental work suggests that Humana's adjudication system has miscoded the service, or that a clinical reviewer has applied an experimental/investigational standard that does not belong to this category of care.
Pre-transplant dental clearance is standard of care endorsed by major transplant medicine organizations. It is neither investigational nor experimental. The appeal should squarely challenge the applicability of the denial reason itself.
## Federal Appeal Rights
Both ERISA §503 and ACA §2719 guarantee you the right to a full internal appeal and then independent external review if the internal appeal is denied. The external-review window is typically four months from the final internal denial. For time-sensitive transplant timelines, request expedited processing in writing at the same time you submit your internal appeal.
## Documentation to Gather
- Transplant program clearance letter — stating which dental procedures are required as a condition of transplant candidacy.
- Transplant physician letter of medical necessity — explicitly addressing that the services are established standard-of-care pre-transplant preparation, not investigational.
- Supporting clinical literature or guideline references — your transplant team can point to the relevant transplant society guidelines (without citing specific statistics) confirming dental clearance as a standard pre-transplant requirement.
- Your plan's own experimental/investigational policy — obtain and review Humana's published definition of "experimental or investigational" to demonstrate that pre-transplant dental care does not meet that definition under any reasonable reading.
## Criteria-Mapping Strategy
In your appeal, make two arguments in parallel. First, challenge the threshold question: the "not FDA-approved" or "experimental" standard simply does not apply to established surgical/dental procedures. Second, in the alternative, show that even under any investigational-services definition Humana uses, pre-transplant dental clearance fails to qualify as investigational. Attach transplant-team documentation labeled as exhibits, and request that an independent external reviewer — preferably with transplant medicine expertise — evaluate the case if the internal appeal is denied.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →